Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G BIOLIFE SOLUTIONS INC Filed by: Casdin Capital, LLC

June 4, 2026 6:37 PM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Casdin Capital, LLC
Signature:/s/ Eli Casdin
Name/Title:Eli Casdin, Managing Member
Date:06/04/2026
Casdin Partners Master Fund, L.P.
Signature:s/ Eli Casdin
Name/Title:Eli Casdin, Managing Member of its General Partner
Date:06/04/2026
Casdin Partners GP, LLC
Signature:/s/ Eli Casdin
Name/Title:Eli Casdin, Managing Member
Date:06/04/2026
Eli Casdin
Signature:/s/ Eli Casdin
Name/Title:Eli Casdin
Date:06/04/2026

Comments accompanying signature: * Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. To the extent that "ownership of 5 percent or less of a class" was indicated in Item 5, such response only applies to the Reporting Person(s) that indicated elsewhere herein that it beneficially owns five percent (5%) or less of the class.
Exhibit Information

Exhibit A - Joint Filing Agreement

ATTACHMENTS / EXHIBITS

p12174694_ex-a.htm

Categories

SEC Filings